Ryan Allway January 20th, 2022 TORONTO, Jan. 20, 2022 /CNW/ – Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the “Company” or “Canntab”), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the official launch of its online e-commerce platform and web site... Read more